Skip to main content
Top
Published in: Endocrine 1/2017

01-01-2017 | Editorial

Does testicular anti-Müllerian hormone extend life?

Authors: Ian S. McLennan, Yih Harng Chong

Published in: Endocrine | Issue 1/2017

Login to get access

Excerpt

Men tend to have shorter lives than women, with the gonads appearing to contributing to this. Gonadal hormones decline from midlife in men, but few elderly men become totally devoid of testicular hormones, the male equivalent of menopause [1]. The systemic metabolic demands created by gonadal hormones are therefore more extended in men than women. When the testicular influence is lessened by castration at a young age, the resulting eunuchs typically outlive intact men by over a decade [2]. This supports the theory that the testes facilitate reproductive success, at the expensive of longevity. …
Literature
1.
go back to reference Y.H. Chong, M.P. Pankhurst, I.S. McLennan, The testicular hormones AMH, inhb, insl3 and testosterone can be independently deficient in older men. J. Gerontol. A. (2016). doi:10.1093/gerona/glw143 Y.H. Chong, M.P. Pankhurst, I.S. McLennan, The testicular hormones AMH, inhb, insl3 and testosterone can be independently deficient in older men. J. Gerontol. A. (2016). doi:10.​1093/​gerona/​glw143
2.
go back to reference J.D. Wilson, C. Roehrborn, Long-term consequences of castration in men: Lessons from the skoptzy and the eunuchs of the chinese and ottoman courts. J. Clin. Endocrinol. Metab. 84, 4324–4331 (1999)CrossRefPubMed J.D. Wilson, C. Roehrborn, Long-term consequences of castration in men: Lessons from the skoptzy and the eunuchs of the chinese and ottoman courts. J. Clin. Endocrinol. Metab. 84, 4324–4331 (1999)CrossRefPubMed
3.
go back to reference R. Qayyum, S. Akbar, Serum anti-mullerian hormone and all-cause mortality in men. Endocrine 54, 225–231 (2016)CrossRefPubMed R. Qayyum, S. Akbar, Serum anti-mullerian hormone and all-cause mortality in men. Endocrine 54, 225–231 (2016)CrossRefPubMed
4.
go back to reference I.S. McLennan, M.W. Pankhurst, Anti-mullerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. J. Endocrinol. 226, R45–R57 (2015)CrossRefPubMed I.S. McLennan, M.W. Pankhurst, Anti-mullerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. J. Endocrinol. 226, R45–R57 (2015)CrossRefPubMed
5.
go back to reference N. Lebeurrier, S. Launay, R. Macrez, E. Maubert, H. Legros, A. Leclerc, S.P. Jamin, J.Y. Picard, S. Marret, V. Laudenbach, P. Berger, P. Sonderegger, C. Ali, N. di Clemente, D. Vivien, Anti-mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin. J. Cell. Sci. 121, 3357–3365 (2008)CrossRefPubMed N. Lebeurrier, S. Launay, R. Macrez, E. Maubert, H. Legros, A. Leclerc, S.P. Jamin, J.Y. Picard, S. Marret, V. Laudenbach, P. Berger, P. Sonderegger, C. Ali, N. di Clemente, D. Vivien, Anti-mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin. J. Cell. Sci. 121, 3357–3365 (2008)CrossRefPubMed
Metadata
Title
Does testicular anti-Müllerian hormone extend life?
Authors
Ian S. McLennan
Yih Harng Chong
Publication date
01-01-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1162-8

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue

Pros and Cons in Endocrine Practice

Premixed insulin regimens in type 2 diabetes: pros

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.